48,475
edits
Difference between revisions of "Medical kidney diseases"
Jump to navigation
Jump to search
Medical kidney diseases (view source)
Revision as of 04:42, 10 November 2010
, 04:42, 10 November 2010→Calcineurin-inhibitor toxicity
m (→Myeloma: re-arr.) |
|||
| Line 579: | Line 579: | ||
===Calcineurin-inhibitor toxicity=== | ===Calcineurin-inhibitor toxicity=== | ||
*Calcineurin-inhibitors (e.g. cyclosporine,<ref name=pmid10354295>{{cite journal |author=Zarifian A, Meleg-Smith S, O'donovan R, Tesi RJ, Batuman V |title=Cyclosporine-associated thrombotic microangiopathy in renal allografts |journal=Kidney Int. |volume=55 |issue=6 |pages=2457–66 |year=1999 |month=June |pmid=10354295 |doi=10.1046/j.1523-1755.1999.00492.x |url=}}</ref>, tacrolimus<ref name=Ref_FoRP203>{{Ref FoRP|203}}</ref>) toxicity can induce a [[thrombotic microangiopathy]]. | *Calcineurin-inhibitors (e.g. cyclosporine,<ref name=pmid10354295>{{cite journal |author=Zarifian A, Meleg-Smith S, O'donovan R, Tesi RJ, Batuman V |title=Cyclosporine-associated thrombotic microangiopathy in renal allografts |journal=Kidney Int. |volume=55 |issue=6 |pages=2457–66 |year=1999 |month=June |pmid=10354295 |doi=10.1046/j.1523-1755.1999.00492.x |url=}}</ref>, tacrolimus<ref name=Ref_FoRP203>{{Ref FoRP|203}}</ref>) toxicity can induce a [[thrombotic microangiopathy]]. | ||
*Hyaline arteriopathy with a peripheral and nodular distribution (chronic toxicity). | |||
==See also== | ==See also== | ||